WHO ICTRP trial
Early Predictive parameters of Immunosuppressive therapy in Crohn's disease…
DRKS00010935 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00010935 |
|---|---|
| Public title | Early Predictive parameters of Immunosuppressive therapy in Crohn's disease (EPIC) |
| Scientific title | Early Predictive parameters of Immunosuppressive therapy in Crohn's disease (EPIC) |
| Primary sponsor | AbbVie Deutschland GmbH & Co. KG |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | K50;Crohn disease [regional enteritis] |
| Interventions | Group 1: Patients with a new diagnosis of active Crohn's disease: documentation of demographic data, history of Crohn's disease, previous extraintestinal manifestations, treatment with Case Report Forms for 24 months |
| Registration date | Nov 1, 2018 |
| Target size | 300 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: